RxNorm Semantic Concepts Index - 680
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "680".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 68011 | 4-hydroxybenzoate-CoA synthetase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 68011 | 4-hydroxybenzoate-CoA synthetase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 68011 | 4-hydroxybenzoate-CoA synthetase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 68011 | 4-hydroxybenzoate-CoA synthetase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 6802 | Metamucil | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 6804 | Orciprenaline sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 6804 | Orciprenaline sulfate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 6804 | Orciprenaline sulfate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 6804 | Orciprenaline sulfate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 6805 | Metaraminol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 6805 | Metaraminol | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 6805 | Metaraminol | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 6805 | Metaraminol | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 6805 | Metaraminol | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 6806 | Metaraminol tartrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 6806 | Metaraminol tartrate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 6806 | Metaraminol tartrate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 6806 | Metaraminol tartrate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 68084 | Sesquiterpene cyclase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 68084 | Sesquiterpene cyclase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 68084 | Sesquiterpene cyclase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 6809 | Metformin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 6809 | Metformin | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 6809 | Metformin | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 6809 | Metformin | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 6809 | Metformin | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 6809 | Metformin | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 68091 | Dolasetron | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 68091 | Dolasetron | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 68091 | Dolasetron | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 68091 | Dolasetron | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 68091 | Dolasetron | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 68092 | lanreotide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 68092 | lanreotide | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 68092 | lanreotide | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 68092 | lanreotide | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 68092 | lanreotide | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 680973 | Soliris | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 68099 | famciclovir | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 68099 | famciclovir | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 68099 | famciclovir | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 68099 | famciclovir | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 68099 | famciclovir | Full form of descriptor (FN) | YES |